Validation

  The present work describes the development of stability indicating assay method for Diacerein and Aceclofenac in their combined dosage form that would provide helpful information to the manufacturers. Stress studies were conducted on the drug substance and product under the ICH prescribed stress conditions viz. hydrolysis, oxidation, humidity, photolysis, thermal stress. The separation of the drug from its degradation products, trials were made by taking acetonitrile: water, acetonitrile: phosphate buffer, acetonitrile: phosphoric acid in various blends. Separation was achieved using C-18 column and a mobile phase comprising of Acetonitrile: Phosphoric acid 0.1 M (61: 39) at a flow rate of 1.5 mL/min. The detection wavelength was 260 nm. The drug showed sufficient decomposition under alkaline hydrolysis (0.05 N NaOH), acidic hydrolysis (0.05 N HCl), neutral hydrolysis (distilled water), and oxidative hydrolysis (6% H2O2). The drug was found to be moderately sensitive to humidity studies (75 % RH), photochemical studies (UV 254 nm), and thermal studies (600C). Recovery studies were also carried out for both the drugs and the mean percent recovery were found to be 100.69 for diacerein and 99.15 for aceclofenac. Mean percent estimation in marketed formulation gave 99.63% for diacerein and 100.04% for aceclofenac. The above method was validated for accuracy, precision, ruggedness, limit of detection, limit of quantitation and was found to be satisfactory for routine analysis of diacerein and aceclofenac in their combined dosage form in the presence of their degradation products.   Key words: Aceclofenac, Diacerein, Stress Degradation, Stability Indicating, Validation

A simple, sensitive and rugged quantitative method for the determination of Clopidogrel in human plasma (K2EDTA) using liquid chromatography-tandem mass spectrometric (LC-MS/MS) method has been developed and validated. Clopidogrel-d3 was used as an internal standard. Analyte and the internal standards were extracted from human plasma by liquid-liquid extraction technique using Methyl tertiary butyl ether as extraction solvent and 0.5% formic acid as extraction buffer. The reconstituted samples were chromatographed on a C18 column by using acetonitrile / 5mM ammonium acetate (90/10, V/V) as the mobile phase. The method was validated over the concentration range of 101.98–61028.96 pg/mL. The Quattro Premier XE mass spectrometry was operated under the multiple reaction-monitoring mode (MRM) using the electrospray ionization technique for quantification of ion transitions at m/z 322.13/212.04 and 326.06/215.04 for the drug and the internal standard respectively. The results of the intra and inter batch precision and accuracy studies were well within the acceptable limits. The method has been proved to be simple, sensitive, fast, reliable, rugged and reproducible. A run time of 2.50 min for each sample made it possible to analyze more than 400 plasma samples per day. The proposed method can be applied for the estimation of the drug in real time plasma samples for pharmacokinetic studies. Key words: Clopidogrel, Validation, Human Plasma, LC-MS/MS, Electrospray ionization.